You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
中牧股份(600195.SH)子公司獲2個新獸藥註冊證書
格隆匯 11-10 16:39

格隆匯11月10日丨中牧股份(600195.SH)公佈,根據《獸藥管理條例》和《獸藥註冊辦法》規定,農業農村部審查批准公司的子公司湖北中牧安達藥業有限公司、中牧全藥(南京)動物藥品有限公司分別與其他單位聯合申報的兩個產品為新獸藥(沙咪珠利及沙咪珠利溶液),核發《新獸藥註冊證書》。

沙咪珠利屬於三嗪類抗球蟲藥,主要作用於球蟲的裂殖生殖和配子生殖階段,作用峯期為感染後3~4日。對雞的柔嫩、堆型、毒害和巨型艾美耳球蟲感染有良好的防治效果。此次獲得新獸藥證書將對豐富公司化藥產品序列,提升市場競爭力產生積極影響。

截至目前以上兩個新獸藥產品發生的研發費用共計225萬元。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account